
Roivant Sciences Ltd.
USD28.70
+0.45 (+1.59%)
CEO
Matthew Gline
IPO Date
2020-12-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
GB
Open
$28.29
Prev. Close
$28.25
Day Low
$28.18
Day High
$28.80
52W Low
$10.71
52W High
$32.79
Market Cap
$20.64B
Volume
3.41M
| 21 May 2026 |
| TD Cowen |
| Buy |
| Buy |
| maintain |
| 16 Apr 2026 | Piper Sandler | Overweight | Overweight | maintain |
| 4 Mar 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 10 Feb 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 10 Feb 2026 | Citigroup | Buy | Buy | maintain |
| 9 Feb 2026 | Guggenheim | Buy | Buy | maintain |
| 15 Dec 2025 | Leerink Partners | Outperform | Outperform | maintain |